Nicotinic attenuation of cns inflammation and autoimmunity

Details Nicotinic attenuation of cns inflammation and autoimmunity Nicotinic attenuation of cns inflammation and autoimmunity

A - Human Necessities

61

K

A61K 31/465 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2736871

The present invention relates to methods of treating and/or ameliorating the severity of inflammation and autoim-munity in the central nervous system (CNS). In one embodiment, the present invention provides a method of treating multiple sclerosis by administering a therapeutically effective dosage of nicotine, or a pharmaceutical equivalent, analog, derivative, or salt thereof.

La présente invention concerne des procédés de traitement et/ou damélioration de la gravité dune inflammation et de lauto-immunité dans le système nerveux central (SNC). Dans un mode de réalisation, la présente invention concerne un procédé de traitement de la sclérose en plaques par administration dune dose thérapeutiquement efficace de nicotine, ou dun équivalent pharmaceutique, un analogue, un dérivé, ou un sel de celle-ci.

Affiliated with

Also associated with

Rating

Nicotinic attenuation of cns inflammation and autoimmunity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nicotinic attenuation of cns inflammation and autoimmunity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotinic attenuation of cns inflammation and autoimmunity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1475700